Multiple Organ Dysfunction Syndrome clinical trials at UCSD

1 research study open to eligible people

Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
open to eligible people ages up to 17 years
The TRIPS study is a prospective, multi-center, double-blind, adaptively randomized, placebo-controlled clinical trial of the drug anakinra for reversal of moderate to severe hyperinflammation in children with sepsis-induced multiple organ dysfunction syndrome (MODS).
San Diego, California and other locations

Last updated: July 2, 2025